SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,209 | -26.7% | 21,386 | -1.8% | 0.00% | – |
| Q2 2023 | $101,287 | +12.8% | 21,782 | +12.0% | 0.00% | – |
| Q1 2023 | $89,826 | -82.3% | 19,443 | -69.0% | 0.00% | – |
| Q4 2022 | $506,939 | +54.1% | 62,740 | +5.8% | 0.00% | – |
| Q3 2022 | $329,000 | +2.8% | 59,302 | -3.3% | 0.00% | – |
| Q2 2022 | $320,000 | -28.1% | 61,318 | +13.3% | 0.00% | – |
| Q1 2022 | $445,000 | -82.0% | 54,131 | -67.4% | 0.00% | -100.0% |
| Q4 2021 | $2,474,000 | -62.1% | 166,222 | -51.9% | 0.00% | -50.0% |
| Q3 2021 | $6,520,000 | +4.3% | 345,237 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $6,252,000 | -6.3% | 336,290 | +14.8% | 0.00% | 0.0% |
| Q1 2021 | $6,670,000 | +357.2% | 293,033 | +336.1% | 0.00% | – |
| Q4 2020 | $1,459,000 | – | 67,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |